The Relationship of Omental and Subcutaneous Adipocyte Size to Metabolic Disease in Severe Obesity
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Several studies have reported the existence of a subgroup of obese individuals with normal metabolic profiles. It remains unclear what factors are responsible for this phenomenon. We proposed that adipocyte size might be a key factor in the protection of metabolically healthy obese (MHO) individuals from the adverse effects of obesity. SUBJECTS: Thirty-five patients undergoing bariatric surgery were classified as MHO (n = 15) or metabolically unhealthy obese (MUO, n = 20) according to cut-off points adapted from the International Diabetes Federation definition of the metabolic syndrome. Median body mass index (BMI) was 48 (range 40-71). RESULTS: There was a moderate correlation between omental adipocyte size and subcutaneous adipocyte size (r = 0.59, p<0.05). The MHO group had significantly lower mean omental adipocyte size (80.9+/-10.9 microm) when compared with metabolically unhealthy patients (100.0+/-7.6 microm, p<0.0001). Mean subcutaneous adipocyte size was similar between the two groups (104.1+/-8.5 microm versus 107.9+/-7.1 microm). Omental, but not subcutaneous adipocyte size, correlated with the degree of insulin resistance as measured by HOMA-IR (r = 0.73, p<0.0005), as well as other metabolic parameters including triglyceride/HDL-cholesterol ratio and HbA1c. Twenty-eight patients consented to liver biopsy. Of these, 46% had steatohepatitis and fibrosis. Fifty percent (including all the MHO patients) had steatosis only. Both omental and subcutaneous adipocyte size were significantly associated with the degree of steatosis (r = 0.66, p<0.0001 and r = 0.63, p<0.005 respectively). However, only omental adipocyte size was an independent predictor of the presence or absence of fibrosis. CONCLUSION: Metabolically healthy individuals are a distinct subgroup of the severely obese. Both subcutaneous and omental adipocyte size correlated positively with the degree of fatty liver, but only omental adipocyte size was related to metabolic health, and possibly progression from hepatic steatosis to fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Demographics ranging between men, women, and postmenopausal women show that there is a correlation between a beneficial phenotype for metabolic outcomes and subcutaneous fat accumulation, whereas visceral fat accumulation, including omental adipocyte hypertrophy, leads to a decline in metabolic health (20–25).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [23]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“However, larger adipocytes are positively correlated with adipose tissue macrophage number and production of pro-inflammatory cytokines TNF-a and IL-6 in mice[42].”
BackgroundAdipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · cited 1×
“‘two hit’ hypothesis for steatohepatitis[46].”
Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome
Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · cited 1×
“Depot-related differences exist in adipocyte responses to lipolytic and lipogenic stimuli, in adipocyte apoptosis, expression of adipokine receptors, and secretion of adipokines[13,14,15,16].”
BackgroundIndependent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610 · cited 1×
“Recent studies indicate that the histological severity of NAFLD correlates with the indices of the metabolic syndrome, particularly degree of insulin resistance[40,41].”
BackgroundRelationship between Adipocyte Size and Adipokine Expression and Secretion
Skurk, T., Alberti-Huber, C., Herder, C., & Hauner, H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1055 · Cited by 1,288 · cited 2×
“Large adipocytes are more likely to produce pro-inflammatory adipokines[12] and to demonstrate increased basal and catecholamine-stimulated lipolysis[24].”
BackgroundScherer, P. E. (2006) · Diabetes · doi:10.2337/db06-0263 · Cited by 1,066
Identification and characterization of metabolically benign obesity in humans
Stefan, N. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.15.1609 · Cited by 1,049 · cited 4×
“Other studies have investigated the factors responsible for protecting MHO individuals from developing co-morbidities such as diabetes and dyslipidemia[4,5,6].”
BackgroundInfluentialWeyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799
Gender differences in fat metabolism
Blaak, E. (2001) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200111000-00006 · Cited by 709 · cited 1×
“women than in men, whereas free fatty acid release from the upper body depots is comparable[38].”
Background
Cited by
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319
Adipose tissue inflammation and metabolic dysfunction in obesity
Kawai, T., Autieri, M. V., & Scalia, R. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00379.2020 · Cited by 1,947
Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders
Choe, S. S., Huh, J. Y., Hwang, I. J., Kim, J. I., & Kim, J. B. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00030 · Cited by 1,206
“A frequent feature of the MHO population is a lower number of immune cells and a higher proportion of relatively small adipocytes in adipose tissues (77, 114, 115, 117).”
BackgroundChronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“Cross-sectional studies have demonstrated that the size of visceral adipocytes is negatively correlated with insulin sensitivity (O’Connell et al., 2010; Hardy et al., 2011), and these findings allow proposing adipocyte size as an IR determinant (O’Connell et al.”
BackgroundSamson, S. L., & Garber, A. J. (2014) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2013.09.009 · Cited by 746
Metabolically healthy obesity: facts and fantasies
Smith, G. I., Mittendorfer, B., & Klein, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129186 · Cited by 645
McArdle, M. A., Finucane, O. M., Connaughton, R. M., McMorrow, A. M., & Roche, H. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00052 · Cited by 532
“MHO individuals have significantly smaller omental adipocytes than metabolically unhealthy individuals (O’Connell et al., 2010).”
BackgroundLynch, L., Nowak, M., Varghese, B., Clark, J., Hogan, A. E., Toxavidis, V., Balk, S. P., O’Shea, D., O’Farrelly, C., & Exley, M. A. (2012) · Immunity · doi:10.1016/j.immuni.2012.06.016 · Cited by 512
“We and others have shown that increasing adipocyte size correlates with insulin resistance, triglyceride levels, and the degree of hepatic steatosis (Lönn et al., 2010; O’Connell et al., 2010).”
BackgroundSelf-citationImpaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity
Hammarstedt, A., Gogg, S., Hedjazifar, S., Nerstedt, A., & Smith, U. (2018) · Physiological Reviews · doi:10.1152/physrev.00034.2017 · Cited by 462
Metabolically healthy versus metabolically unhealthy obesity
Iacobini, C., Pugliese, G., Blasetti Fantauzzi, C., Federici, M., & Menini, S. (2019) · Metabolism · doi:10.1016/j.metabol.2018.11.009 · Cited by 453
Obesity and the risk of cardiometabolic diseases
Valenzuela, P. L., Carrera-Bastos, P., Castillo-García, A., Lieberman, D. E., Santos-Lozano, A., & Lucia, A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-023-00847-5 · Cited by 452
Borlaug, B. A., Jensen, M. D., Kitzman, D. W., Lam, C. S. P., Obokata, M., & Rider, O. J. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvac120 · Cited by 450
Contribution of Adipose Tissue Inflammation to the Development of Type 2 Diabetes Mellitus
Burhans, M. S., Hagman, D. K., Kuzma, J. N., Schmidt, K. A., & Kratz, M. (2018) · Comprehensive Physiology · doi:10.1002/cphy.c170040 · Cited by 373
Adipose tissue fibrosis, hypertrophy, and hyperplasia: Correlations with diabetes in human obesity
Muir, L. A., Neeley, C. K., Meyer, K. A., Baker, N. A., Brosius, A. M., Washabaugh, A. R., Varban, O. A., Finks, J. F., Zamarron, B. F., Flesher, C. G., et al. (2016) · Obesity · doi:10.1002/oby.21377 · Cited by 367
“In our study, the observed positive correlation of hypertrophy with diabetes and inverse correlation with fibrosis support this hypothesis, and are consistent with multiple prior data that separately demonstrate similar relationships between adipocyte size and diabetes/insulin resistance (2-6,30) and between adipocyte”
ResultNew obesity classification criteria as a tool for bariatric surgery indication
Lorenzo, A. D. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.681 · Cited by 306
Hocking, S., Samocha-Bonet, D., Milner, K.-L., Greenfield, J. R., & Chisholm, D. J. (2013) · Endocrine Reviews · doi:10.1210/er.2012-1041 · Cited by 276
“Abdominal visceral fat tissue 2 (404–411) 7 (412) Liver lipid 2 (411, 412) Abdominal adipose tissue adipocyte size 2 Subcutaneous and visceral depots (405, 413) 7 Subcutaneous depot (414) Circulating adiponectin 1 (405, 410, 411, 415) 7 (412) Skeletal muscle triacylglycerol content 2 (364, 410, 412)”
BackgroundWhite adipose tissue mitochondrial metabolism in health and in obesity
Heinonen, S., Jokinen, R., Rissanen, A., & Pietiläinen, K. H. (2020) · Obesity Reviews · doi:10.1111/obr.12958 · Cited by 240
Adipocyte size as a determinant of metabolic disease and adipose tissue dysfunction
Laforest, S., Labrecque, J., Michaud, A., Cianflone, K., & Tchernof, A. (2015) · Critical Reviews in Clinical Laboratory Sciences · doi:10.3109/10408363.2015.1041582 · Cited by 214
“Also, the number of metabolic syndrome features increased with visceral FCS (25), 358 consistent with another study (22) (adapted version of (68)) that associated adipocyte hypertrophy with a 359 detrimental metabolic state in bariatric patients.”
BackgroundWhite adipocyte dysfunction and obesity-associated pathologies in humans
Hagberg, C. E., & Spalding, K. L. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00680-1 · Cited by 209
“Additional studies confirm the relationship between VAT adipocyte size and metabolic dysfunction, including insulin resistance, glycated haemoglobin and dyslipidaemia 70 .”
Lin, L., Saha, P. K., Ma, X., Henshaw, I. O., Shao, L., Chang, B. H. J., Buras, E. D., Tong, Q., Chan, L., McGuinness, O. P., et al. (2011) · Aging Cell · doi:10.1111/j.1474-9726.2011.00740.x · Cited by 187
“Increasing evidence has shown that adipocyte cell size, but not adipocyte cell number, is correlated with insulin resistance (O’Connell et al., 2010).”
BackgroundThe regulation of adipose tissue health by estrogens
Steiner, B. M., & Berry, D. C. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.889923 · Cited by 171
“On the other hand, adipocyte size appears to be equivalent in males and obese females’ fat pads (123).”
BackgroundAll-Cause Mortality Risk of Metabolically Healthy Obese Individuals in NHANES III
Durward, C. M., Hartman, T. J., & Nickols-Richardson, S. M. (2012) · Journal of Obesity · doi:10.1155/2012/460321 · Cited by 149
Bays, H. (2014) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0000000000000093 · Cited by 142
Adipose tissue in obesity and obstructive sleep apnoea
Bonsignore, M. R., McNicholas, W. T., Montserrat, J. M., & Eckel, J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00047010 · Cited by 137
Hyaluronan Accumulates With High-Fat Feeding and Contributes to Insulin Resistance
Kang, L., Lantier, L., Kennedy, A., Bonner, J. S., Mayes, W. H., Bracy, D. P., Bookbinder, L. H., Hasty, A. H., Thompson, C. B., & Wasserman, D. H. (2013) · Diabetes · doi:10.2337/db12-1502 · Cited by 133
Badoud, F., Perreault, M., Zulyniak, M. A., & Mutch, D. M. (2015) · The FASEB Journal · doi:10.1096/fj.14-263913 · Cited by 127
“In contrast, MHO individuals appear to have smaller adipocytes (;15%smaller) than theirMUOcounterparts (18, 43, 44).”
BackgroundSaravanan, S., & Pari, L. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.034 · Cited by 137
“The enhanced circulation of LDL cholesterol and TG in blood alters the activity of adiponectin and leptin proteins, thus being involved in several syndromes such as obesity, steatosis, diabetes and artherosclerosis (O’Connell et al., 2010).”
Background4D polycarbonates via stereolithography as scaffolds for soft tissue repair
Weems, A. C., Arno, M. C., Wei, Y., Huckstepp, R. T. R., & Dove, A. P. (2021) · Nature Communications · doi:10.1038/s41467-021-23956-6 · Cited by 126
Adipose Tissue: Physiology to Metabolic Dysfunction
Richard, A. J., White, U. A., Elks, C. M., & Stephens, J. M. (2020) · Europe PMC (PubMed Central) · Cited by 224
MicroRNAs in adipogenesis and as therapeutic targets for obesity
Alexander, R., Lodish, H. F., & Sun, L. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.561317 · Cited by 125
Recent insights into the molecular pathophysiology of lipid droplet formation in hepatocytes
Sahini, N., & Borlak, J. T. (2014) · Progress in Lipid Research · doi:10.1016/j.plipres.2014.02.002 · Cited by 126
Adipose tissue in health and disease
Harvey, I., Boudreau, A., & Stephens, J. M. (2020) · Open Biology · doi:10.1098/rsob.200291 · Cited by 113
“This notion is supported by clinical studies reporting that increased adipocyte size is associated with insulin resistance, hepatic steatosis and other markers of metabolic dysfunction [27,28,35].”
BackgroundLiu, F., He, J., Wang, H., Zhu, D., & Bi, Y. (2020) · Obesity Surgery · doi:10.1007/s11695-020-04983-6 · Cited by 112
Of mice and men: Pinpointing species differences in adipose tissue biology
Börgeson, E., Boucher, J., & Hagberg, C. E. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1003118 · Cited by 141
“It is therefore important to recognize that in humans the adipocyte size relationship between fat pads is the opposite, with the more beneficial abdominal subcutaneous fat displaying larger fat cell sizes, especially in lean individuals, than the human visceral oWAT (Belligoli et al., 2019; O’Connell et al., 2010).”
BackgroundMetabolically Healthy Obesity—Heterogeneity in Definitions and Unconventional Factors
Brandão, I., Martins, M. J., & Monteiro, R. (2020) · Metabolites · doi:10.3390/metabo10020048 · Cited by 123
Insulin-sensitive obesity in humans – a ‘favorable fat’ phenotype?
Samocha‐Bonet, D., Chisholm, D. J., Tonks, K. T. T., Campbell, L. V., & Greenfield, J. R. (2012) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.12.005 · Cited by 123
Does bariatric surgery improve adipose tissue function?
Frikke‐Schmidt, H., O'Rourke, R. W., Lumeng, C. N., Sandoval, D. A., & Seeley, R. J. (2016) · Obesity Reviews · doi:10.1111/obr.12429 · Cited by 108
Ye, R. Z., Richard, G., Gévry, N., Tchernof, A., & Carpentier, A. C. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab018 · Cited by 101
Gonzalez, E., Maratos–Flier, E., Molle, D., Accili, D., & McGraw, T. E. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1019268108 · Cited by 116
“For instance, enlarged adipocyte size has been correlated with changes in adipocyte function and metabolic disease (39, 40).”
BackgroundMeißburger, B., Ukropec, J., Roeder, E., Beaton, N., Geiger, M., Teupser, D., Civan, B., Langhans, W., Nawroth, P. P., Gašperíková, D., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100172 · Cited by 116
Wree, A., Schlattjan, M., Bechmann, L. P., Claudel, T., Sowa, J., Stojaković, T., Scharnagl, H., Köfeler, H. C., Baba, H. A., Gerken, G., et al. (2014) · Metabolism · doi:10.1016/j.metabol.2014.09.001 · Cited by 108
“the visceral adipose tissue of severely obese patients is correlated neither with their bodyweight nor with BMI was made regardless of patients’ gender or age and is in line with a recent study by O’Connell [20].”
BackgroundResultHuang, C.-W., Chien, Y.-S., Chen, Y.-J., Ajuwon, K., Mersmann, H., & Ding, S.-T. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101689 · Cited by 100
“Both subcutaneous and omental adipocyte sizes correlate positively with the degree of fatty livers, but only omental adipocyte size is related to metabolic syndrome [104].”
BackgroundInflammatory processes in the liver: divergent roles in homeostasis and pathology
Ahmed, O., Robinson, M. W., & O’Farrelly, C. (2021) · Cellular and Molecular Immunology · doi:10.1038/s41423-021-00639-2 · Cited by 111
Self-citationKranendonk, M. E. G., van Herwaarden, J. A., Stupkova, T., Jager, W. D., Vink, A., Moll, F. L., Kalkhoven, E., & Visseren, F. L. J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.035 · Cited by 91
Open questions about metabolically normal obesity
Pataky, Z., Bobbioni-Harsch, E., & Golay, A. (2010) · International Journal of Obesity · doi:10.1038/ijo.2010.235 · Cited by 105
Growth hormone and adipose tissue: Beyond the adipocyte
Berryman, D. E., List, E. O., Sackmann‐Sala, L., Lubbers, E. R., Munn, R. D., & Kopchick, J. J. (2011) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2011.03.002 · Cited by 99
“Depot-specific differences in mean adipocyte size have been reported for rodents and humans [39–42].”
BackgroundSaad, F., & Gooren, L. J. (2011) · Journal of Obesity · doi:10.1155/2011/471584 · Cited by 82
“Adolescent boys lose subcutaneous fat but accumulate fat in the abdominal region, which in most boys, is not very visible in that stage of development but clearly demonstrable with imaging techniques [7].”
BackgroundRegulatory mechanisms of the early phase of white adipocyte differentiation: an overview
Audano, M., Pedretti, S., Caruso, D., Crestani, M., Fabiani, E. D., & Mitro, N. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04169-6 · Cited by 97
Obesity and diabetes: the link between adipose tissue dysfunction and glucose homeostasis
Abranches, M. V., Oliveira, F. C. E. D., Conceição, L. L. D., & Peluzio, M. D. C. G. (2015) · Nutrition Research Reviews · doi:10.1017/s0954422415000098 · Cited by 78
“A study conducted by O’Connell et al.(53) revealed that the size of omental adipocytes in obese metabolically healthy individuals is smaller than the size of adipocytes in unhealthy individuals.”
MethodPascual‐Serrano, A., Arola‐Arnal, A., Suárez‐Garcia, S., Bravo, F. I., Suárez, M., Arola, L., & Bladé, C. (2017) · International Journal of Obesity · doi:10.1038/ijo.2017.90 · Cited by 81
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease
Tarantino, G., Scopacasa, F., Colao, A., Capone, D., Tarantino, M., Grimaldi, E., & Savastano, S. (2011) · World Journal of Gastroenterology · doi:10.3748/wjg.v17.i48.5280 · Cited by 73
Pereira, S. S., Teixeira, L. G., Aguilar, E. C., Oliveira, M. C., Savassi-Rocha, A. L., Pelaez, J. M. N., Capettini, L. D. S. A., Diniz, M. T. C., Ferreira, A. V. M., & Alvarez-Leite, J. I. (2013) · Nutrition · doi:10.1016/j.nut.2013.11.023 · Cited by 75
Adipose Tissue and FoxO1: Bridging Physiology and Mechanisms
Ioannilli, L., Ciccarone, F., & Ciriolo, M. R. (2020) · Cells · doi:10.3390/cells9040849 · Cited by 73
“In the long-term, impaired lipid utilization in adipocytes might have deleterious outcomes; in fact, enlarged adipocyte size has been correlated with changes in adipocyte function and metabolic disease [69].”
BackgroundMetabolically healthy obesity and metabolically obese normal weight: a review
Gómez‐Zorita, S., Queralt, M., Vicente, M. Á., González, M. A., & Portillo, M. P. (2021) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00781-x · Cited by 90
“In good accordance with these concepts, in several reported studies, MHO subjects have shown smaller adipocytes than their metabolic unhealthy obese (MUO) counterparts [59, 78, 120].”
ResultTrehalose prevents adipocyte hypertrophy and mitigates insulin resistance
Arai, C., Arai, N., Mizote, A., Kohno, K., Iwaki, K., Hanaya, T., Arai, S., Ushio, S., & Fukuda, S. (2010) · Nutrition Research · doi:10.1016/j.nutres.2010.10.009 · Cited by 67
“Because of these data, visceral adipocyte size has been frequently examined in obese animal models as an indicator of insulin resistance and its mitigation by foods and medications [19-24].”
BackgroundBuemann, B., & Uvnäs-Moberg, K. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.109597 · Cited by 66
Review article: fructose in non‐alcoholic fatty liver disease
Yilmaz, Y. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05080.x · Cited by 65
“In a small clinical study of 35 obese patients undergoing bariatric surgery, O’Connell et al.(60) reported that both omental and subcutaneous adipocyte size measured in biopsy sample were significantly associated with”
BackgroundA novel automated image analysis method for accurate adipocyte quantification
Osman, O. S., Selway, J. L., Kępczyńska, M. A., Stocker, C. J., O’Dowd, J. F., Cawthorne, M. A., Arch, J. R. S., Jassim, S., & Langlands, K. (2013) · Adipocyte · doi:10.4161/adip.24652 · Cited by 64
“Performance of our algorithm was consistent with routinely utilized manual methods 10,11 and, moreover, we were able to establish increased accuracy in unsupervised area measurements.”
MethodDe Lorenzo, A., Costacurta, M., Merra, G., Gualtieri, P., Cioccoloni, G., Marchetti, M., Varvaras, D., Docimo, R., & Di Renzo, L. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1236-2 · Cited by 62
“Different obese phenotypes have been described based on body fat composition and distribution, rather than the simple increase of body weight, body mass index (BMI) and genetics [21]: (1) metabolically obese normal weight [22]; (2) metabolically healthy obese [23]; and (3) Trial registration ClinicalTrials.”
BackgroundWhite adipocytes: More than just fat depots
Henry, S. L., Bensley, J. G., Wood‐Bradley, R. J., Cullen‐McEwen, L. A., Bertram, J. F., & Armitage, J. A. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.12.011 · Cited by 84
Preadipocyte Factor-1 Is Associated with Metabolic Profile in Severe Obesity
O’Connell, J., Lynch, L., Hogan, A. E., Cawood, T., & O'Shea, D. B. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2026 · Cited by 61
Self-citationRole of developmental transcription factors in white, brown and beige adipose tissues
Hilton, C., Karpe, F., & Pinnick, K. E. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.02.003 · Cited by 67
Wang, X., & Hai, C. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.07.012 · Cited by 65
Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes
Teixeira, T. F., Alves, R. D. M., Moreira, A. P. B., & Pelúzio, M. D. C. G. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuu007 · Cited by 68
Metabolic Syndrome and Cardiovascular Disease: A Health Challenge
González-Chávez, A., Chávez-Fernández, J. A., Elizondo-Argueta, S., González-Tapia, A., León-Pedroza, J. I., & Ochoa, C. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.003 · Cited by 68
de Sá, R. D. C. D. C., Crisma, A. R., Cruz, M. M., Martins, A. R., Masi, L. N., do Amaral, C. L., Curi, R., & Alonso‐Vale, M. I. C. (2016) · The Journal of Physiology · doi:10.1113/jp272541 · Cited by 55
“Obesity, type-2 diabetes mellitus (T2DM) and metabolic syndrome are associated with changes in metabolism and the secretion of hormones and adipokines, such as adiponectin, resistin, tumour necrosis factor (TNF) and interleukin (IL)-6 in white adipose tissue (WAT) (Smith & Minson, 2012; Bluher, 2013; Omatsu-Kanbe & Ma…”
BackgroundInfluentialMeißburger, B., Perdikari, A., Moest, H., Müller, S., Geiger, M., & Wolfrum, C. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.06.010 · Cited by 57
Ibrahim, L. I., Hajal, C., Offeddu, G. S., Gillrie, M. R., & Kamm, R. D. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121728 · Cited by 53
Moreno‐Navarrete, J. M., Ortega, F. J., Serrano, M., Rodríguez‐Hermosa, J. I., Ricart, W., Mingrone, G., & Fernández‐Real, J. M. (2013) · International Journal of Obesity · doi:10.1038/ijo.2013.171 · Cited by 56
Cuffe, H., Liu, M., Key, C.-C. C., Boudyguina, E. Y., Sawyer, J. K., Weckerle, A., Bashore, A. C., Fried, S. K., Chung, S., & Parks, J. S. (2018) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.117.309880 · Cited by 49
Human CD206+ macrophages associate with diabetes and adipose tissue lymphoid clusters
Muir, L. A., Cho, K. W., Geletka, L. M., Baker, N. A., Flesher, C. G., Ehlers, A. P., Kaciroti, N., Lindsly, S., Ronquist, S., Rajapakse, I., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.146563 · Cited by 56
“…tolerance testing in our human cohort, but we have demonstrated that our methods of categorizing DM using clinical diagnosis and HbA1c levels correlate strongly with molecular and cellular characteristics of adipose tissue (32–35), suggesting that DM is the main driver of the associations observed.”
Is Adipose Tissue Inflammation the Culprit of Obesity‐Associated Comorbidities?
Turner, L., Wanasinghe, A. I., Brunori, P., & Santosa, S. (2025) · Obesity Reviews · doi:10.1111/obr.13956 · Cited by 68
“…s i z e [ 11 , 27 , 32 , 41 , 42 ] ( ♂ > ♀ ) [ 28 , 43 ] ∝ I R [ 30 , 40 , 42 ] ∝ N A F L D [ 36 , 37 , 44 ] ∝ C V D [ 45 ] S A T > V A T [ 11 , 26 , 31 , 33 , 35 , 46 ] ↑ s i z e [ 11 , 41 , 47 , 48 ] ( g f S A T > a b S A T > V A T ) ( ♂ > ♀ ) [ 49 ] ↑ s i z e [ 50 – 53 ] ∝ b r e a s t C A r i…”
InfluentialWoods, C. P., Corrigan, M., Gathercole, L., TAYLOR, A. E. R., Hughes, B. A., Gaoatswe, G., Manolopoulos, K. N., Hogan, A. E., O’Connell, J., Stewart, P. M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-4120 · Cited by 55
“For gene expression assays, archived tissue samples were also used from patients who had undergone bariatric surgery in St Columcille’s Hospital previously (43, 44).”
MethodSelf-citationTynan, G. A., Hearnden, C. H. A., Oleszycka, E., Lyons, C. L., Coutts, G., O’Connell, J., Corrigan, M. A., Lynch, L., Campbell, M., Callanan, J. J., et al. (2014) · Diabetes · doi:10.2337/db13-1476 · Cited by 52
Self-citationPark, H. T., Lee, E. S., Cheon, Y., Lee, D. R., Yang, K., Kim, Y. T., Hur, J. Y., Kim, S. H., Lee, K. W., & Kim, T. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04141.x · Cited by 53
de Velde, H. V., Janssens, G. P. J., de Rooster, H., Polis, I., Peters, I. R., Ducatelle, R., Nguyen, P., Buyse, J. G., Rochus, K., Xu, J., et al. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513000226 · Cited by 59
Delaney, K. Z., & Santosa, S. (2022) · Obesity Reviews · doi:10.1111/obr.13393 · Cited by 56
“Humans F Obese > in SAT of unresolved T2DM than resolved T2DM O'Connell et al.(38) Humans M and F Obese Association with HOMA-IR: r = 0.”
BackgroundStop feeding cancer: Pro-inflammatory role of visceral adiposity in liver cancer
Zhao, J., & Lawless, M. W. (2013) · Cytokine · doi:10.1016/j.cyto.2013.09.009 · Cited by 47
Wolf, D., Jehle, F., Rodríguez, A. O., Dufner, B., Hoppe, N., Colberg, C., Lozhkin, A. P., Bassler, N., Rupprecht, B., Wiedemann, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033026 · Cited by 45
Adipokines: biological functions and metabolically healthy obese profile
Pereira, S. S., & Alvarez-Leite, J. I. (2014) · Journal of Receptor Ligand and Channel Research · doi:10.2147/jrlcr.s36060 · Cited by 55
“24,30 These results suggest that the CCL2–CCR2 axis plays an important role in the development of insulin resistance by inducing inflammatory response on adipose tissue, and also plays an important role in the pathogenesis of metabolic syndrome and obesity-associated T2DM.”
Expression of inflammation-related genes is associated with adipose tissue location in horses
Bruynsteen, L., Erkens, T., Peelman, L. J., Ducatelle, R., Janssens, G. P. J., Harris, P. A., & Hesta, M. (2013) · BMC Veterinary Research · doi:10.1186/1746-6148-9-240 · Cited by 45
Mulder, P., Morrison, M. C., Verschuren, L., Liang, W., van Bockel, J. H., Kooistra, T., Wielinga, P. Y., & Kleemann, R. (2016) · Scientific Reports · doi:10.1038/srep31542 · Cited by 42
“Consistent with this, meta-bolically healthy obese subjects were found to have significantly smaller adipocytes compared with metabolically unhealthy obese patients who had more ectopic liver fat at a comparable body mass index 28 .”
Adiposity-Dependent Regulatory Effects on Multi-tissue Transcriptomes
Glastonbury, C. A., Viñuela, A., Buil, A., Halldorsson, G. H., Þorleifsson, G., Helgason, H., Þorsteinsdóttir, U., Stefánsson, K., Dermitzakis, E. T., Spector, T. D., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.07.001 · Cited by 39
de Sá, R. D. C. C., Cruz, M. M., Farias, T. M., da Silva, V. S., Simão, J. D. J., Telles, M. M., & Alonso‐Vale, M. I. C. (2020) · Physiological Reports · doi:10.14814/phy2.14380 · Cited by 38
“In addition to impaired metabolic functions, hypertrophied cells present an altered secretory pattern, resulting in increased secretion of pro-inflammatory cytokines, and, according to the literature, reduction of anti-inflammatory adipokines (Moraes-vieira, Yore, Dwyer, Syed, & Aryal, 2015; MorenoAliaga, Lorente-Cebr…”
BackgroundMacrophage and Adipocyte Mitochondrial Dysfunction in Obesity-Induced Metabolic Diseases
Wang, L., Hu, J., & Zhou, H. (2020) · The World Journal of Men s Health · doi:10.5534/wjmh.200163 · Cited by 39
“Based on a cross-sectional study, the size of visceral adipocytes is negatively related with insulin sensitivity and regarded as an IR determinant [33].”
BackgroundIL-1β promotes adipogenesis by directly targeting adipocyte precursors
Hofwimmer, K., Souza, J. D. P., Subramanian, N., Vujičić, M., Rachid, L., Méreau, H., Zhao, C., Dror, E., Barreby, E., Björkström, N. K., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51938-x · Cited by 37
Lazra, Y., Malik, A. F. , Argaev-Frenkel, L., Rozenberg, K., Sampson, S. R., & Rosenzweig, T. (2015) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25031 · Cited by 35
The impact of obesity on pentraxin 3 and inflammatory milieu to acute aerobic exercise
Slusher, A. L., Mock, J. T., WHITEHURST, M. A., Maharaj, A., & Huang, C. (2014) · Metabolism · doi:10.1016/j.metabol.2014.10.022 · Cited by 38
“[29] O'Connell J, LynchL,CawoodTJ, KwasnikA,NolanN,Geoghegan J, et al.”
BackgroundZhang, Y., Zheng, Y., Fu, Y., & Wang, C. (2019) · Adipocyte · doi:10.1080/21623945.2019.1649578 · Cited by 36
“ders are associated more strongly with visceral adiposity, rather than with subcutaneous adiposity [27].”
BackgroundSun, W., von Meyenn, F., Peleg‐Raibstein, D., & Wolfrum, C. (2019) · Advanced Science · doi:10.1002/advs.201900275 · Cited by 37
Wenderott, J. K., Flesher, C. G., Baker, N. A., Neeley, C. K., Varban, O. A., Lumeng, C. N.-K., Muhammad, L. N., Yeh, C., Green, P. F., & O’Rourke, R. W. (2020) · Scientific Reports · doi:10.1038/s41598-020-77498-w · Cited by 35
Hirata, B. K. S., Pedroso, A. P., Machado, M. M. F., Neto, N. I. P., Perestrelo, B. D. O., de Sá, R. D. C. C., Alonso‐Vale, M. I. C., Nogueira, F. N., Oyama, L. M., Ribeiro, E. B., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00686 · Cited by 27
“Since obesity-related chronic low-grade inflammation is associated with insulin resistance and type 2 diabetes (O’Connell et al., 2010), it is possible that the benefits associated with GbE on insulin sensitivity and signaling are related to the reduction in adipocyte hypertrophy and the expression of proteins involve…”
BackgroundAustvoll, C. T., Gallo, V., & Montag, D. (2020) · Global Health · doi:10.1017/gheg.2020.2 · Cited by 27
“Study subjects were classified as (1) metabolically obese/normal-weight [121]; (2) metabolically healthy/obese [122]; (3) metabolically unhealthy/obese or ‘at risk’ obese [120] and (4) normal weight obese syndrome [123].”
Jin, A., Lei, C., Tian, J., Sun, J. H., & Ji, H. (2017) · Fish Physiology and Biochemistry · doi:10.1007/s10695-017-0424-6 · Cited by 26
“Obesity is characterized by an excessive increase of white adipose tissue and associated with metabolic diseases such as type 2 diabetes, cardiovascular disease, and some cancers (Aggoun 2007; Frayn et al. 2006; Jean et al. 2010).”
BackgroundLee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Mouse model of the adipose organ: the heterogeneous anatomical characteristics
Chun, K. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01350-6 · Cited by 31
Pin, L., Li, C., Huang, J., & Ji, H. (2014) · Fish Physiology and Biochemistry · doi:10.1007/s10695-014-9939-2 · Cited by 24
“It is widely accepted that excessive development of white adipose tissue in humans leads to obesity as well as related metabolic diseases such as type 2 diabetes, cardiovascular disease (CVD) and some cancers (Frayn et al. 2006; Grundy 2004; O’Connell et al. 2010).”
BackgroundEffect of diosgenin on metabolic dysfunction: Role of ERβ in the regulation of PPARγ
Wang, X., Liu, J., Long, Z., Sun, Q., Liu, Y., Wang, L., Zhang, X., & Hai, C. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.09.015 · Cited by 25
Relationship of Adipocyte Size with Adiposity and Metabolic Risk Factors in Asian Indians
Meena, V. P., Seenu, V., Sharma, M. C., Mallick, S., Bhalla, A. S., Gupta, N., Mohan, A., Guleria, R., Pandey, R. M., Luthra, K., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108421 · Cited by 27
Petäjä, E. M., Sevastianova, K., Hakkarainen, A., Orho‐Melander, M., Lundbom, N. M. I., & Yki‐Järvinen, H. (2013) · Obesity · doi:10.1002/oby.20114 · Cited by 25
“reported in (3,6,23,24), but the present data are novel as the impact”
Background
Metadata
- Authors
- O'Connell, J., Lynch, L., Cawood, T. J., Kwasnik, A., Nolan, N., Geoghegan, J., McCormick, A., O'Farrelly, C., & O'Shea, D.
- Affiliations
- St. Vincent's University Hospital (IE)
- Christchurch Hospital (NZ)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-04-01
- Volume
- 5
- Issue
- 4
- Pages
- e9997
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2848665
- OpenAlex
- W2115664664
- Cited by
- 211
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 11 · 2023: 4 · 2022: 14 · 2021: 14 · 2020: 19 · 2019: 16 · 2018: 11 · 2017: 11 · 2016: 16 · 2015: 18 · 2014: 19 · 2013: 18 · 2012: 9
- FWCI
- 11.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Arrow@dit (Dublin Institute of Technology) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
- Lenus, The Irish Health Repository (Dr Steevens Hospital Library) (submittedVersion)
- Funders
- Medical Research Charities Group
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
- Keywords
- metabolically healthy obesity, omental adipocytes, subcutaneous adipocytes, adipocyte size, morbid obesity, insulin resistance, hepatic steatosis, liver fibrosis, steatohepatitis, bariatric surgery, metabolic syndrome, HOMA-IR
- MeSH terms
- Adult, Fatty Liver, Female, Humans, Insulin Resistance, Male, Metabolic Diseases, Middle Aged, Omentum, Body Mass Index, Adipocytes, Metabolic Syndrome, Cell Size, Subcutaneous Fat
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.